Medical Grade Chitosan Market Opportunities, Key Trends, Competitive Benchmarking, Price Outlook and CAGR Forecast Through 2031

QY Research has recently published a research report titled, "Global Medical Grade Chitosan Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", assessing various factors impacting its trajectory. The research study offers deep evaluation of the global Medical Grade Chitosan market and helps market participants to gain a strong foothold in the industry. It sheds light on critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for any challenges ahead in time. It provides regional analysis of the global Medical Grade Chitosan market to unveil key opportunities available in different parts of the world. The competitive landscape is broadly assessed along with company profiling of leading players operating in the global Medical Grade Chitosan market. The report provides detailed statistics and accurate market figures, viz. market share, CAGR, gross margin, and those related to revenue, production, consumption, and sales.

The global market for Medical Grade Chitosan was estimated to be worth US$ 64.27 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart)@ https://www.qyresearch.in/request-sample/pharma-healthcare-medical-grade-chitosan-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Medical Grade Chitosan cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In the current market, medical-grade chitosan refers to highly purified, specification-controlled chitosan that meets pharmaceutical or medical device expectations on bioburden, residuals, and defined structural parameters such as degree of deacetylation and molecular-weight distribution. As a cationic polysaccharide obtained by partial deacetylation of chitin, it offers hemostatic action, film-forming, and bioadhesion that make it valuable for wound care, emergency hemostats, drug delivery matrices, and tissue scaffolds. Suppliers differentiate by source-marine crustacean versus non-animal fungal origin-by form (powder, solutions, or salts/derivatives), and by quality systems (e.g., ISO 13485 and EU-GMP) that enable use in regulated settings. USP/NF defines chitosan and accepts DDA in a 70-95% window, anchoring analytical consistency for buyers and regulators.

In the current market, global production is around 650 t with an average selling price of about USD 64.27 per kg(EXW basis). Top suppliers together control roughly half to two-thirds of value, driven by qualification hurdles and brand trust in regulated applications; the supply landscape features marine-sourced leaders in Europe and Asia and a growing non-animal fungal segment in Europe. Demand is most visible in North America and Europe where cleared hemostats and wound products are widely used, with China and the broader Indo-Pacific ramping on both the supply and demand sides. Toward 2025-2031, the direction is steady expansion into drug-delivery adjuncts and tissue engineering, gradual mix-shift toward non-animal sources where regulatory or customer preferences require it, and continuing cost/quality optimization. Potential bottlenecks include variability in upstream chitin supply, the capital and documentation burden of ISO 13485/EU-GMP production, and device-side regulatory timelines that pace downstream offtake. Illustrative evidence includes USP/NF definitions, 510(k) device clearances, and supplier quality disclosures.

Leading players of the global Medical Grade Chitosan market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Medical Grade Chitosan market. Furthermore, the report offers two separate market forecasts - one for the production side and another for the consumption side of the global Medical Grade Chitosan market. It also provides useful recommendations for new as well as established players of the global Medical Grade Chitosan market.

Key Players Mentioned in the Global Medical Grade Chitosan Market Research Report:

Heppe Medical Chitosan GmbH
Kitozyme S.A.
Primex EHF (Primex Ingredients)
FMC Corporation
Advanced Biopolymers AS
Golden-Shell Pharmaceuticals Co., Ltd.
G.T.C. Bio Corporation
Panvo Organics Pvt. Ltd.
Qingdao Yunzhou Biochemistry Co., Ltd.
KitoSano SL
Vietnam Food
NovaMatrix
KIMICA
ChitoLytic
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology

Market Segments

Our market analysts are experts in deeply segmenting the global Medical Grade Chitosan market and thoroughly evaluating the growth potential of each and every segment studied in the report. Right at the beginning of the research study, the segments are compared on the basis of consumption and growth rate for a review period of nine years. The segmentation study included in the report offers a brilliant analysis of the global Medical Grade Chitosan market, taking into consideration the market potential of different segments studied. It assists market participants to focus on high-growth areas of the global Medical Grade Chitosan market and plan powerful business tactics to secure a position of strength in the industry.

Details of Medical Grade Chitosan Market Segmentation: -

Segment by Type:

Marine (Crustacean-derived)
Fungal (Non-animal)

Segment by Application:

Wound Care & Exudate Management
Hemostats & Emergency Care
Pharma Excipients & Drug Delivery
Tissue Engineering & Regenerative Medicine
Medical Cosmetology
Other Medical Uses

All of the segments studied in the research study are analyzed on the basis of BPS, market share, revenue, and other important factors. Our research study shows how different segments are contributing to the growth of the global Medical Grade Chitosan market. It also provides information on key trends related to the segments included in the report. This helps market players to concentrate on high-growth areas of the global Medical Grade Chitosan market. The research study also offers separate analysis on the segments on the basis of absolute dollar opportunity.

Segment by Region

North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

How can the research study help your business?

(1) The information presented in the Medical Grade Chitosan report helps your decision makers to become prudent and make the best business choices.

(2) The report enables you to see the future of the global Medical Grade Chitosan market and accordingly take decisions that will be in the best interest of your business.

(3) It offers you a forward-looking perspective of the global Medical Grade Chitosan market drivers and how you can secure significant market gains in the near future.

(4) It provides SWOT analysis of the global Medical Grade Chitosan market along with useful graphics and detailed statistics providing quick information about the market's overall progress throughout the forecast period.

(5) It also assesses the changing competitive dynamics of the global Medical Grade Chitosan market using pin-point evaluation.

Request Pre-Order Enquiry or Customized Research on This Report: https://www.qyresearch.in/pre-order-inquiry/pharma-healthcare-medical-grade-chitosan-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Table of Contents

1 Market Overview
1.1 Medical Grade Chitosan Product Introduction
1.2 Global Medical Grade Chitosan Market Size Forecast
1.2.1 Global Medical Grade Chitosan Sales Value (2020-2031)
1.2.2 Global Medical Grade Chitosan Sales Volume (2020-2031)
1.2.3 Global Medical Grade Chitosan Sales Price (2020-2031)
1.3 Medical Grade Chitosan Market Trends & Drivers
1.3.1 Medical Grade Chitosan Industry Trends
1.3.2 Medical Grade Chitosan Market Drivers & Opportunity
1.3.3 Medical Grade Chitosan Market Challenges
1.3.4 Medical Grade Chitosan Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Grade Chitosan Players Revenue Ranking (2024)
2.2 Global Medical Grade Chitosan Revenue by Company (2020-2025)
2.3 Global Medical Grade Chitosan Players Sales Volume Ranking (2024)
2.4 Global Medical Grade Chitosan Sales Volume by Company Players (2020-2025)
2.5 Global Medical Grade Chitosan Average Price by Company (2020-2025)
2.6 Key Manufacturers Medical Grade Chitosan Manufacturing Base and Headquarters
2.7 Key Manufacturers Medical Grade Chitosan Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Medical Grade Chitosan
2.9 Medical Grade Chitosan Market Competitive Analysis
2.9.1 Medical Grade Chitosan Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Medical Grade Chitosan Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Grade Chitosan as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Source
3.1 Introduction by Source
3.1.1 Marine (Crustacean-derived)
3.1.2 Fungal (Non-animal)
3.2 Global Medical Grade Chitosan Sales Value by Source
3.2.1 Global Medical Grade Chitosan Sales Value by Source (2020 VS 2024 VS 2031)
3.2.2 Global Medical Grade Chitosan Sales Value, by Source (2020-2031)
3.2.3 Global Medical Grade Chitosan Sales Value, by Source (%) (2020-2031)
3.3 Global Medical Grade Chitosan Sales Volume by Source
3.3.1 Global Medical Grade Chitosan Sales Volume by Source (2020 VS 2024 VS 2031)
3.3.2 Global Medical Grade Chitosan Sales Volume, by Source (2020-2031)
3.3.3 Global Medical Grade Chitosan Sales Volume, by Source (%) (2020-2031)
3.4 Global Medical Grade Chitosan Average Price by Source (2020-2031)
4 Segmentation by Form
4.1 Introduction by Form
4.1.1 Powder/Flake
4.1.2 Salts & Derivatives
4.2 Global Medical Grade Chitosan Sales Value by Form
4.2.1 Global Medical Grade Chitosan Sales Value by Form (2020 VS 2024 VS 2031)
4.2.2 Global Medical Grade Chitosan Sales Value, by Form (2020-2031)
4.2.3 Global Medical Grade Chitosan Sales Value, by Form (%) (2020-2031)
4.3 Global Medical Grade Chitosan Sales Volume by Form
4.3.1 Global Medical Grade Chitosan Sales Volume by Form (2020 VS 2024 VS 2031)
4.3.2 Global Medical Grade Chitosan Sales Volume, by Form (2020-2031)
4.3.3 Global Medical Grade Chitosan Sales Volume, by Form (%) (2020-2031)
4.4 Global Medical Grade Chitosan Average Price by Form (2020-2031)
5 Segmentation by Channel
5.1 Introduction by Channel
5.1.1 Direct Sale
5.1.2 Indirect Sale
5.2 Global Medical Grade Chitosan Sales Value by Channel
5.2.1 Global Medical Grade Chitosan Sales Value by Channel (2020 VS 2024 VS 2031)
5.2.2 Global Medical Grade Chitosan Sales Value, by Channel (2020-2031)
5.2.3 Global Medical Grade Chitosan Sales Value, by Channel (%) (2020-2031)
5.3 Global Medical Grade Chitosan Sales Volume by Channel
5.3.1 Global Medical Grade Chitosan Sales Volume by Channel (2020 VS 2024 VS 2031)
5.3.2 Global Medical Grade Chitosan Sales Volume, by Channel (2020-2031)
5.3.3 Global Medical Grade Chitosan Sales Volume, by Channel (%) (2020-2031)
5.4 Global Medical Grade Chitosan Average Price by Channel (2020-2031)
6 Segmentation by Application
6.1 Introduction by Application
6.1.1 Wound Care & Exudate Management
6.1.2 Hemostats & Emergency Care
6.1.3 Pharma Excipients & Drug Delivery
6.1.4 Tissue Engineering & Regenerative Medicine
6.1.5 Medical Cosmetology
6.1.6 Other Medical Uses
6.2 Global Medical Grade Chitosan Sales Value by Application
6.2.1 Global Medical Grade Chitosan Sales Value by Application (2020 VS 2024 VS 2031)
6.2.2 Global Medical Grade Chitosan Sales Value, by Application (2020-2031)
6.2.3 Global Medical Grade Chitosan Sales Value, by Application (%) (2020-2031)
6.3 Global Medical Grade Chitosan Sales Volume by Application
6.3.1 Global Medical Grade Chitosan Sales Volume by Application (2020 VS 2024 VS 2031)
6.3.2 Global Medical Grade Chitosan Sales Volume, by Application (2020-2031)
6.3.3 Global Medical Grade Chitosan Sales Volume, by Application (%) (2020-2031)
6.4 Global Medical Grade Chitosan Average Price by Application (2020-2031)
7 Segmentation by Region
7.1 Global Medical Grade Chitosan Sales Value by Region
7.1.1 Global Medical Grade Chitosan Sales Value by Region: 2020 VS 2024 VS 2031
7.1.2 Global Medical Grade Chitosan Sales Value by Region (2020-2025)
7.1.3 Global Medical Grade Chitosan Sales Value by Region (2026-2031)
7.1.4 Global Medical Grade Chitosan Sales Value by Region (%), (2020-2031)
7.2 Global Medical Grade Chitosan Sales Volume by Region
7.2.1 Global Medical Grade Chitosan Sales Volume by Region: 2020 VS 2024 VS 2031
7.2.2 Global Medical Grade Chitosan Sales Volume by Region (2020-2025)
7.2.3 Global Medical Grade Chitosan Sales Volume by Region (2026-2031)
7.2.4 Global Medical Grade Chitosan Sales Volume by Region (%), (2020-2031)
7.3 Global Medical Grade Chitosan Average Price by Region (2020-2031)
7.4 North America
7.4.1 North America Medical Grade Chitosan Sales Value, 2020-2031
7.4.2 North America Medical Grade Chitosan Sales Value by Country (%), 2024 VS 2031
7.5 Europe
7.5.1 Europe Medical Grade Chitosan Sales Value, 2020-2031
7.5.2 Europe Medical Grade Chitosan Sales Value by Country (%), 2024 VS 2031
7.6 Asia Pacific
7.6.1 Asia Pacific Medical Grade Chitosan Sales Value, 2020-2031
7.6.2 Asia Pacific Medical Grade Chitosan Sales Value by Region (%), 2024 VS 2031
7.7 South America
7.7.1 South America Medical Grade Chitosan Sales Value, 2020-2031
7.7.2 South America Medical Grade Chitosan Sales Value by Country (%), 2024 VS 2031
7.8 Middle East & Africa
7.8.1 Middle East & Africa Medical Grade Chitosan Sales Value, 2020-2031
7.8.2 Middle East & Africa Medical Grade Chitosan Sales Value by Country (%), 2024 VS 2031
8 Segmentation by Key Countries/Regions
8.1 Key Countries/Regions Medical Grade Chitosan Sales Value Growth Trends, 2020 VS 2024 VS 2031
8.2 Key Countries/Regions Medical Grade Chitosan Sales Value and Sales Volume
8.2.1 Key Countries/Regions Medical Grade Chitosan Sales Value, 2020-2031
8.2.2 Key Countries/Regions Medical Grade Chitosan Sales Volume, 2020-2031
8.3 United States
8.3.1 United States Medical Grade Chitosan Sales Value, 2020-2031
8.3.2 United States Medical Grade Chitosan Sales Value by Source (%), 2024 VS 2031
8.3.3 United States Medical Grade Chitosan Sales Value by Application, 2024 VS 2031
8.4 Europe
8.4.1 Europe Medical Grade Chitosan Sales Value, 2020-2031
8.4.2 Europe Medical Grade Chitosan Sales Value by Source (%), 2024 VS 2031
8.4.3 Europe Medical Grade Chitosan Sales Value by Application, 2024 VS 2031
8.5 China
8.5.1 China Medical Grade Chitosan Sales Value, 2020-2031
8.5.2 China Medical Grade Chitosan Sales Value by Source (%), 2024 VS 2031
8.5.3 China Medical Grade Chitosan Sales Value by Application, 2024 VS 2031
8.6 Japan
8.6.1 Japan Medical Grade Chitosan Sales Value, 2020-2031
8.6.2 Japan Medical Grade Chitosan Sales Value by Source (%), 2024 VS 2031
8.6.3 Japan Medical Grade Chitosan Sales Value by Application, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Medical Grade Chitosan Sales Value, 2020-2031
8.7.2 South Korea Medical Grade Chitosan Sales Value by Source (%), 2024 VS 2031
8.7.3 South Korea Medical Grade Chitosan Sales Value by Application, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Medical Grade Chitosan Sales Value, 2020-2031
8.8.2 Southeast Asia Medical Grade Chitosan Sales Value by Source (%), 2024 VS 2031
8.8.3 Southeast Asia Medical Grade Chitosan Sales Value by Application, 2024 VS 2031
8.9 India
8.9.1 India Medical Grade Chitosan Sales Value, 2020-2031
8.9.2 India Medical Grade Chitosan Sales Value by Source (%), 2024 VS 2031
8.9.3 India Medical Grade Chitosan Sales Value by Application, 2024 VS 2031
9 Company Profiles
9.1 Primex
9.1.1 Primex Company Information
9.1.2 Primex Introduction and Business Overview
9.1.3 Primex Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.1.4 Primex Medical Grade Chitosan Product Offerings
9.1.5 Primex Recent Development
9.2 KitoZyme
9.2.1 KitoZyme Company Information
9.2.2 KitoZyme Introduction and Business Overview
9.2.3 KitoZyme Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.2.4 KitoZyme Medical Grade Chitosan Product Offerings
9.2.5 KitoZyme Recent Development
9.3 BIO21
9.3.1 BIO21 Company Information
9.3.2 BIO21 Introduction and Business Overview
9.3.3 BIO21 Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.3.4 BIO21 Medical Grade Chitosan Product Offerings
9.3.5 BIO21 Recent Development
9.4 YSK
9.4.1 YSK Company Information
9.4.2 YSK Introduction and Business Overview
9.4.3 YSK Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.4.4 YSK Medical Grade Chitosan Product Offerings
9.4.5 YSK Recent Development
9.5 Vietnam Food
9.5.1 Vietnam Food Company Information
9.5.2 Vietnam Food Introduction and Business Overview
9.5.3 Vietnam Food Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.5.4 Vietnam Food Medical Grade Chitosan Product Offerings
9.5.5 Vietnam Food Recent Development
9.6 NovaMatrix
9.6.1 NovaMatrix Company Information
9.6.2 NovaMatrix Introduction and Business Overview
9.6.3 NovaMatrix Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.6.4 NovaMatrix Medical Grade Chitosan Product Offerings
9.6.5 NovaMatrix Recent Development
9.7 KIMICA
9.7.1 KIMICA Company Information
9.7.2 KIMICA Introduction and Business Overview
9.7.3 KIMICA Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.7.4 KIMICA Medical Grade Chitosan Product Offerings
9.7.5 KIMICA Recent Development
9.8 Heppe Medical Chitosan GmbH
9.8.1 Heppe Medical Chitosan GmbH Company Information
9.8.2 Heppe Medical Chitosan GmbH Introduction and Business Overview
9.8.3 Heppe Medical Chitosan GmbH Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.8.4 Heppe Medical Chitosan GmbH Medical Grade Chitosan Product Offerings
9.8.5 Heppe Medical Chitosan GmbH Recent Development
9.9 ChitoLytic
9.9.1 ChitoLytic Company Information
9.9.2 ChitoLytic Introduction and Business Overview
9.9.3 ChitoLytic Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.9.4 ChitoLytic Medical Grade Chitosan Product Offerings
9.9.5 ChitoLytic Recent Development
9.10 Golden-Shell Pharmaceutical
9.10.1 Golden-Shell Pharmaceutical Company Information
9.10.2 Golden-Shell Pharmaceutical Introduction and Business Overview
9.10.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.10.4 Golden-Shell Pharmaceutical Medical Grade Chitosan Product Offerings
9.10.5 Golden-Shell Pharmaceutical Recent Development
9.11 Zhejiang Fengrun Biotech
9.11.1 Zhejiang Fengrun Biotech Company Information
9.11.2 Zhejiang Fengrun Biotech Introduction and Business Overview
9.11.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.11.4 Zhejiang Fengrun Biotech Medical Grade Chitosan Product Offerings
9.11.5 Zhejiang Fengrun Biotech Recent Development
9.12 Jiangsu Shuanglin
9.12.1 Jiangsu Shuanglin Company Information
9.12.2 Jiangsu Shuanglin Introduction and Business Overview
9.12.3 Jiangsu Shuanglin Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.12.4 Jiangsu Shuanglin Medical Grade Chitosan Product Offerings
9.12.5 Jiangsu Shuanglin Recent Development
9.13 Jiangsu Aoxin Biotechnology
9.13.1 Jiangsu Aoxin Biotechnology Company Information
9.13.2 Jiangsu Aoxin Biotechnology Introduction and Business Overview
9.13.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.13.4 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product Offerings
9.13.5 Jiangsu Aoxin Biotechnology Recent Development
9.14 Qingdao Yunzhou Biochemistry
9.14.1 Qingdao Yunzhou Biochemistry Company Information
9.14.2 Qingdao Yunzhou Biochemistry Introduction and Business Overview
9.14.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2020-2025)
9.14.4 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product Offerings
9.14.5 Qingdao Yunzhou Biochemistry Recent Development
10 Industry Chain Analysis
10.1 Medical Grade Chitosan Industrial Chain
10.2 Medical Grade Chitosan Upstream Analysis
10.2.1 Key Raw Materials
10.2.2 Raw Materials Key Suppliers
10.2.3 Manufacturing Cost Structure
10.3 Midstream Analysis
10.4 Downstream Analysis (Customers Analysis)
10.5 Sales Model and Sales Channels
10.5.1 Medical Grade Chitosan Sales Model
10.5.2 Sales Channel
10.5.3 Medical Grade Chitosan Distributors
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

Ankit Jain - Director, Global Digital Marketing

QY Research, INC.
India Office -
315Work Avenue, Raheja Woods, Kalyani Nagar,
Pune, Maharashtra 411006, India
Web - https://www.qyresearch.in
Email- ankit@qyresearch.com

This release was published on openPR.